Trends in the prevalence of obstructive and restrictive lung function among adults in the United States: Findings from the National Health and Nutrition Examination Surveys from 1988-1994 to 2007-2010

Chest

Volumn 143, Issue 5, 2013, Pages 1395-1406

  Ford, Earl S ^a   Mannino, David M ^b   Wheaton, Anne G ^a   Giles, Wayne H ^a   Presley Cantrell, Letitia ^a   Croft, Janet B ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEALTH SURVEY; HISPANIC; HUMAN; LUNG DISEASE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; OBSTRUCTIVE LUNG FUNCTION; PREVALENCE; PRIORITY JOURNAL; RESTRICTIVE LUNG FUNCTION; SMOKING; SPIROMETRY; TREND STUDY; UNITED STATES;

EID: 84877617694     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-1135     Document Type: Article

References (28)

1. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance - United States, 1971-2000. MMWR Surveill Summ. 2002;51(6):1-16.
2. Mannino DM, Ford ES, Redd SC. Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination. Am J Med. 2003;114(9):758-762. (Pubitemid 36776358)
3. Eisner MD, Anthonisen N, Coultas D, et al Committee on Nonsmoking COPD, Environmental and Occupational Health Assembly. An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;182(5):693-718.
4. Forey BA, Thornton AJ, Lee PN. Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema. BMC Pulm Med. 2011;11: 36.
5. Andersen ZJ, Hvidberg M, Jensen SS, et al. Chronic obstructive pulmonary disease and long-term exposure to traffic-related air pollution: a cohort study. Am J Respir Crit Care Med. 2011;183(4):455-461.
6. Centers for Disease Control and Prevention. Trends in current cigarette smoking among high school students and adults, United States, 1965-2007. Centers for Disease Control and Prevention website. http://www.cdc.gov/tobacco/data- statistics/tables/trends/cig-smoking/index.htm. Accessed May 3, 2012.
7. US Environmental Protection Agency, Office of Air Quality Planning and Standards. Our nation's air-status and trends through 2008. US Environmental Protection Agency website. http://www.epa.gov/airtrends/2010/. Accessed January 5, 2012.
8. US Department of Health and Human Services. National Center for Health Statistics. Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988-94. Hyattsville, MD: Centers for Disease Control and Prevention, 1994.
9. Centers for Disease Control and Prevention. About the National Health and Nutrition Examination Survey. Centers for Disease Control and Prevention website. http://www.cdc.gov/nchs/nhanes/about-nhanes.htm. Accessed March 18, 2011.
10. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159(1):179-187. (Pubitemid 29036522)
11. Centers for Disease Control and Prevention. Spirometry - 1st test &2nd test bronchodilator studies. Centers for Disease Control and Prevention website. http://www.cdc.gov/nchs/nhanes/nhanes2009-2010/SPX-F.htm. Accessed January 5, 2011.
12. Centers for Disease Control and Prevention. Spirometry - 1st test &2nd test bronchodilator studies. Centers for Disease Control and Prevention website. http://www.cdc.gov/nchs/ nhanes/nhanes2007-2008/SPX-E.htm. Accessed January 5, 2011.
13. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2010). GOLD website. http://www.goldcopd.org/guidelines-global- strategy-for-diagnosis-management.html. Accessed May 3, 2012.
14. Ford ES, Mannino DM, Zhao G, Li C, Croft JB. Changes in mortality among US adults with COPD in two national cohorts recruited from 1971-1975 and 1988-1994. Chest. 2012;141(1):101-110.
15. Anthonisen NR, Connett JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA. 1994;272(19):1497-1505.
16. Wise RA, Kanner RE, Lindgren P, et al Lung Health Study Research Group. The effect of smoking intervention and an inhaled bronchodilator on airways reactivity in COPD: the Lung Health Study. Chest. 2003;124(2):449-458. (Pubitemid 37000119)
17. Strassmann R, Bausch B, Spaar A, Kleijnen J, Braendli O, Puhan MA. Smoking cessation interventions in COPD: a network meta-analysis of randomised trials. Eur Respir J. 2009;34(3):634-640.
18. Hoogendoorn M, Feenstra TL, Hoogenveen RT, Rutten-van Mölken MP. Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD. Thorax. 2010;65(8):711-718.
19. Celli BR, Thomas NE, Anderson JA, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med. 2008;178(4):332-338.
20. Qaseem A, Wilt TJ, Weinberger SE, et al American College of Physicians; American College of Chest Physicians; American Thoracic Society; European Respiratory Society. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011;155(3):179-191.
21. American Lung Association. Chronic obstructive pulmonary disease (COPD) fact Sheet. American Lung Association website. http://www.lungusa.org/lung- disease/copd/resources/facts-figures/COPD-Fact-Sheet.html. Accessed January 7, 2011.
22. Miniño AM, Murphy SL, Xu J, Kochanek KD. Deaths: final data for 2008. Natl Vital Stat Rep. 2011;59(10):1-126.
23. Baraniak A, Sheffield D. The efficacy of psychologically based interventions to improve anxiety, depression and quality of life in COPD: a systematic review and meta-analysis. Patient Educ Couns. 2011;83(1):29-36.
24. National Institutes of Health. Morbidity & mortality: 2009 Chartbook on cardiovascular, lung, and blood diseases. National Heart, Lung and Blood Institute website. http://www.nhlbi.nih.gov/resources/docs/2009-ChartBook.pdf. Accessed May 3, 2012.
25. US Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. Atlanta, Ga: US Dept. of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2006.
26. Pirkle JL, Bernert JT, Caudill SP, Sosnoff CS, Pechacek TF. Trends in the exposure of nonsmokers in the U.S. population to secondhand smoke: 1988-2002. Environ Health Perspect. 2006;114(6):853-858. (Pubitemid 43871733)
27. Chen CI, Burton T, Baker CL, Mastey V, Mannino D. Recent trends in exposure to secondhand smoke in the United States population. BMC Public Health. 2010;10: 359.
28. Hankinson JL, Kawut SM, Shahar E, Smith LJ, Stukovsky KH, Barr RG. Performance of American Thoracic Society-recommended spirometry reference values in a multiethnic sample of adults: the Multi-Ethnic Study of Atherosclerosis (MESA) lung study. Chest. 2010;137(1):138-145.